74 related articles for article (PubMed ID: 7894525)
1. Central activity of 2-amino-3-phosphonopropionic acid (AP3) and its N-methyl analog.
Winnicka MM; Wiśniewski K; Kupczyk-Subotkowska L; Subotkowski W; Mastalerz P
Pol J Pharmacol; 1994; 46(5):395-401. PubMed ID: 7894525
[TBL] [Abstract][Full Text] [Related]
2. 2-amino-3-phosphonopropionic acid (AP3) and its N-methyl analog improve learning and memory in rats.
Winnicka MM; Wiśniewski K; Kupczyk-Subotkowska L; Subotkowski W; Mastalerz P
Pol J Pharmacol; 1995; 47(1):1-7. PubMed ID: 7550543
[TBL] [Abstract][Full Text] [Related]
3. Psychotropic activity of N-methyl-2-amino-4-phosphonobutyric acid (N-methyl AP4).
Zalewska A; Winnicka MM; Wiśniewski K
Pol J Pharmacol; 1996; 48(4):415-23. PubMed ID: 9112682
[TBL] [Abstract][Full Text] [Related]
4. Behavioral activity of 1S,3R-ACPD, an agonist of metabotropic glutamate receptors.
Zalewska A; Wiśniewski K
Pol J Pharmacol; 1997 Aug; 49(4):239-48. PubMed ID: 9437767
[TBL] [Abstract][Full Text] [Related]
5. Central activity of 2-amino-4-phosphonobutyric acid (AP4).
Zalewska A; Winnicka MM; Wiśniewski K
Pol J Pharmacol; 1995; 47(1):9-17. PubMed ID: 7550555
[TBL] [Abstract][Full Text] [Related]
6. Effects of dextromethorphan on dopamine dependent behaviours in rats.
Gaikwad RV; Gaonkar RK; Jadhav SA; Thorat VM; Jadhav JH; Balsara JJ
Indian J Exp Biol; 2007 Aug; 45(8):712-9. PubMed ID: 17877148
[TBL] [Abstract][Full Text] [Related]
7. Neurotoxic effect of high dose of L-(+)-2-amino-3-phosphonopropionic acid in rats after intracaudatal injection.
Yuan F; Wang TY; Xu LX; Sun YL; Luo L; Qu BQ
Acta Pharmacol Sin; 2001 Jun; 22(6):556-60. PubMed ID: 11747764
[TBL] [Abstract][Full Text] [Related]
8. Effects of group I metabotropic glutamate receptors blockade in experimental models of Parkinson's disease.
Dekundy A; Pietraszek M; Schaefer D; Cenci MA; Danysz W
Brain Res Bull; 2006 Apr; 69(3):318-26. PubMed ID: 16564428
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological effects of the metabotropic glutamate receptor 1 antagonist compared with those of the metabotropic glutamate receptor 5 antagonist and metabotropic glutamate receptor 2/3 agonist in rodents: detailed investigations with a selective allosteric metabotropic glutamate receptor 1 antagonist, FTIDC [4-[1-(2-fluoropyridine-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]-N-isopropyl-N-methyl-3,6-dihydropyridine-1(2H)-carboxamide].
Satow A; Maehara S; Ise S; Hikichi H; Fukushima M; Suzuki G; Kimura T; Tanak T; Ito S; Kawamoto H; Ohta H
J Pharmacol Exp Ther; 2008 Aug; 326(2):577-86. PubMed ID: 18487514
[TBL] [Abstract][Full Text] [Related]
10. Conformational changes of the smooth endoplasmic reticulum are facilitated by L-glutamate and its receptors in rat Purkinje cells.
Banno T; Kohno K
J Comp Neurol; 1998 Dec; 402(2):252-63. PubMed ID: 9845247
[TBL] [Abstract][Full Text] [Related]
11. Stereoselective antagonism by enantiomers of alanine and serine of phencyclidine-induced hyperactivity, stereotypy and ataxia in the rat.
Tanii Y; Nishikawa T; Hashimoto A; Takahashi K
J Pharmacol Exp Ther; 1994 Jun; 269(3):1040-8. PubMed ID: 8014848
[TBL] [Abstract][Full Text] [Related]
12. Central action of narcotic analgesics. I. Catalepsy and stereotypy in rats and narcotic analgesics.
Malec D; Fidecka S; Langwiński R
Pol J Pharmacol Pharm; 1977; 29(3):177-93. PubMed ID: 560683
[TBL] [Abstract][Full Text] [Related]
13. The influence of antineoplaston A5 on the central dopaminergic structures.
Juszkiewicz M; Chodkowska A; Burzynski SR; Feldo M; Majewska B; Kleinrok Z
Drugs Exp Clin Res; 1994; 20(4):161-7. PubMed ID: 7813388
[TBL] [Abstract][Full Text] [Related]
14. Effects of buspirone on dopamine dependent behaviours in rats.
Dhavalshankh AG; Jadhav SA; Gaikwad RV; Gaonkar RK; Thorat VM; Balsara JJ
Indian J Physiol Pharmacol; 2007; 51(4):375-86. PubMed ID: 18476392
[TBL] [Abstract][Full Text] [Related]
15. A search for new active amino acids responsible for pharmacological activity of collagen degradation products.
Lutostańska A; Telejko E; Maćkowiak J; Wiśniewski K
Pol J Pharmacol; 1993; 45(3):253-68. PubMed ID: 8220659
[TBL] [Abstract][Full Text] [Related]
16. Central effects of angiotensin II, its fragment and analogues.
Georgiev VP; Klousha VE; Petkov VD; Markovska VL; Svirskis SV; Mountsinietse RK; Anouans ZE
Acta Physiol Pharmacol Bulg; 1984; 10(4):36-43. PubMed ID: 6085530
[TBL] [Abstract][Full Text] [Related]
17. Central action of adrenaline.
Jagiełło-Wójtowicz E
Acta Physiol Pol; 1981; 32(2):169-80. PubMed ID: 7196677
[TBL] [Abstract][Full Text] [Related]
18. Solcoseryl stimulates behavioural activity of rats.
Braszko JJ; Winnicka MM; Wiśniewski K
Acta Physiol Hung; 1996; 84(1):63-72. PubMed ID: 8993676
[TBL] [Abstract][Full Text] [Related]
19. Central action of glucagon.
Morawska D; Sieklucka-Dziuba M; Kleinrok Z
Pol J Pharmacol; 1998; 50(2):125-33. PubMed ID: 9798264
[TBL] [Abstract][Full Text] [Related]
20. MTEP, a new selective antagonist of the metabotropic glutamate receptor subtype 5 (mGluR5), produces antiparkinsonian-like effects in rats.
Ossowska K; Konieczny J; Wolfarth S; Pilc A
Neuropharmacology; 2005 Sep; 49(4):447-55. PubMed ID: 15919101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
